Latest Stock Market News

These stocks 50-day SMA crossed below their 200-day SMAs on February 24.

The stocks of a major e-commerce firm sharply fell by 10%, the largest decline since October 2022. This came after Trump directed restrictions on Chinese investments in the US. This has caused Chinese stocks trading in the US to drop, unlike those in Hong Kong and mainland China, affecting the year’s Chinese tech stock rally.

Mani from Bangalore aims to accumulate Rs 3 crore in 10 years through SIP in mutual funds but has high exposure to midcaps and smallcaps. Abhijit Chokshi advises rebalancing this portfolio towards large-cap funds for stability while maintaining growth potential.

Texmaco Rail & Engineering has signed an MoU with Polish firm Nevomo to develop AI-driven next-generation rail technologies, focusing on Magrail, linear propulsion, and driverless systems. This partnership aims to boost rail efficiency, capacity, and modernize infrastructure globally. A dedicated R&D center will be set up in the GCC region.

Deepak Shenoy, Founder of Capital Mind, discusses ongoing market trends, emphasizing the importance of local manufacturing in India. While the market faces corrections, he highlights sectors like defense and railways showing promise. Despite uncertainties and volatility, he advises investing in fundamentally strong companies and believes the domestic economic outlook is improving compared to six months ago.

Despite market volatility, analysts like Mohit Khanna of Purnartha Investment Advisers remain optimistic about long-term investments in equities. Khanna highlights that recent corrections have improved valuations, presenting lucrative opportunities, especially in midcap and smallcap segments, for investors with a selective, bottom-up strategy.

Axis Securities recommends buying HG Infra Engineering, setting a target price at Rs 0.17. With a current market price of Rs 1084.9, the company s order book stands at Rs 15,080 crore. Significant government projects ensure revenue visibility for the next few years. Revenue diversification into Railways and Solar sectors augurs a projected 15% CAGR growth over FY24-26E.

Sampath Reddy from Azurean Investment Managers highlights investment opportunities in large private sector banks, despite the pains in microfinance and unsecured lending. He also finds consumer staples and certain BFSI segments attractive. However, he advises caution with cement stocks due to ongoing challenges and suggests waiting for further corrections in PSE stocks, especially in railway and defense.

Despite Tesla s plans to enter the Indian market, analysts believe domestic automakers like Mahindra & Mahindra are well-positioned to thrive. Market expert Sandip Sabharwal dismisses fears about Tesla s impact, pointing out the strong demand and established strengths of Indian automakers.

Biocon Biologics has launched YESINTEK, a biosimilar to Stelara, in the United States for treating chronic autoimmune conditions, offering a cost-effective option. This is Biocon s first US product launch since becoming a global biosimilars organization. Biocon shares, currently at Rs 321, have declined 13% year-to-date but gained 42% in the last two years.